Isacco Maretto

Padova, 35131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

Journal: Cancers

Published: May 12, 2026

IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer.

IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer.

Journal: Cancers

Published: December 23, 2025

IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer.

IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer.

Journal: Surgery

Published: June 10, 2024

IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesions.

IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesions.

Journal: Scientific reports

Published: February 18, 2024

Rectal Sparing Approach after preoperative Radio- and/or Chemo-therapy (ReSARCh): a prospective, multicenter, observational study.

Rectal Sparing Approach after preoperative Radio- and/or Chemo-therapy (ReSARCh): a prospective, multicenter, observational study.

Journal: International journal of surgery (London, England)

Published: December 27, 2023

IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.

IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.

Journal: Cancer

Published: September 06, 2023

IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer.

IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer.

Journal: The British journal of surgery

Published: February 17, 2023

IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients - a cohort study.

IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients - a cohort study.

Journal: International journal of surgery (London, England)

Published: September 06, 2022

Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues.

Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues.

Journal: PloS one

Published: March 18, 2020

Local excision in rectal cancer patients with major or complete clinical response after neoadjuvant therapy: a case-matched study.

Local excision in rectal cancer patients with major or complete clinical response after neoadjuvant therapy: a case-matched study.

Journal: International journal of colorectal disease

Published: September 29, 2019

Multicentre randomized clinical trial of colonic J pouch or straight stapled colorectal reconstruction after low anterior resection for rectal cancer.

Multicentre randomized clinical trial of colonic J pouch or straight stapled colorectal reconstruction after low anterior resection for rectal cancer.

Journal: The British journal of surgery

Published: October 05, 2018

Metastatic pattern and new primary tumours after neoadjuvant therapy and surgery in rectal cancer.

Metastatic pattern and new primary tumours after neoadjuvant therapy and surgery in rectal cancer.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: June 02, 2018

Showing 1-12 of 36

Last Updated: 09/26/2026